Sintx Technologies (SINT) Revenue (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.03% |
| Dec 31, 2025 | 39.42% |
| Sep 30, 2025 | 37.75% |
| Jun 30, 2025 | -59.08% |
| Mar 31, 2025 | -31.92% |
| Dec 31, 2024 | -32.17% |
| Sep 30, 2024 | -6.98% |
| Jun 30, 2024 | 25.04% |
| Mar 31, 2024 | -23.84% |
| Dec 31, 2023 | 33.04% |
| Sep 30, 2023 | 33.46% |
| Jun 30, 2023 | -5.75% |
| Mar 31, 2023 | -29.54% |
| Dec 31, 2022 | 79.58% |
| Sep 30, 2022 | 77.50% |
| Jun 30, 2022 | 86.05% |
| Mar 31, 2022 | -21.82% |
| Dec 31, 2021 | -30.96% |
| Sep 30, 2021 | 136.63% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -12.93% |
| Dec 31, 2020 | 75.76% |
| Sep 30, 2020 | -67.65% |
| Jun 30, 2020 | -1.45% |
| Mar 31, 2020 | -17.86% |
| Dec 31, 2019 | 45.66% |
| Sep 30, 2019 | 3.59% |
| Jun 30, 2019 | 72.16% |
| Jun 30, 2018 | -11.00% |
| Mar 31, 2018 | -5.88% |
| Dec 31, 2017 | -17.66% |
| Sep 30, 2017 | -7.86% |
| Jun 30, 2017 | 22.02% |
| Mar 31, 2017 | -28.01% |
| Dec 31, 2016 | 8.11% |
| Sep 30, 2016 | -16.03% |
| Jun 30, 2016 | -3.59% |
| Mar 31, 2016 | -18.10% |
| Dec 31, 2015 | 5.38% |
| Sep 30, 2015 | 1.15% |
| Jun 30, 2015 | 0.78% |
| Mar 31, 2015 | -7.92% |
| Dec 31, 2014 | -14.12% |
| Sep 30, 2014 | 2.78% |
| Jun 30, 2014 | 0.97% |
| Mar 31, 2014 | 1.23% |
| Dec 31, 2013 | 7.78% |
| Sep 30, 2013 | -12.47% |
| Jun 30, 2013 | 15.23% |